Niridazole

This classification denotes an antiprotozoal agent with the molecular formula C6H6N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N116U8Y5QQ, chemically known as 2-imidazolidinone, 1-(5-nitro-2-thiazolyl)- but generally known as niridazole, which bears US NIH Compound Identifier 6093. European Medicines Agency schedules Niridazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09304MIG. The term NIRIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules niridazole in its Anatomical Therapeutic Chemical (ATC) Classification. NIRIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule niridazole under HS 29341000 and SITC 51579. As of Q4 2014, NIRIDAZOLE remains the US FDA Preferred Term for this commodity. Niridazole bears US NLM identifiers UMLS ID C0028113 and NCI Concept Code C90757. SMILES: S1C(N2CCNC2=O)NCC1[N](=O)O.